Other Information.
−Removed: Exhibit Index
−Removed: Exhibit Number
−Removed: Certificate of Incorporation (incorporated by reference to Annex B to the proxy statement/prospectus which forms part of the Registration Statement on Form S-4 filed on March 18, 2019) (File No.
−Removed: Bylaws (incorporated by reference to Annex C to the proxy statement/prospectus which forms part of the Registration Statement on Form S-4 filed on March 18, 2019 (File No.
+Added: Certificate of Incorporation of Arcturus Therapeutics Holdings Inc.
+Added: Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-3, filed with the SEC on May 8, 2020 (File No.
+Added: Bylaws of Arcturus Therapeutics Holdings Inc.
+Added: Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-3, filed with the SEC on May 8, 2020 (File No.
Agreement and Plan of Merger and Reorganization, by and between Alcobra Ltd., Aleph MergerSub, Inc.
1 unchanged sentence
Incorporated by reference to Exhibit 99.2 to the Company’s Report of Foreign Private Issuer on Form 6-K filed on September 28, 2017 (File No.
+Added: 2020 Employee Stock Purchase Plan.
+Added: Incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-8, filed with the SEC on August 5, 2020 (File No.
+Added: Amended and Restated 2019 Omnibus Equity Incentive Plan.
+Added: Incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-8, filed with the SEC on August 5, 2020 (File No.
Form of Indemnification Agreement.
Incorporated by reference to Exhibit 10.1 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed on March 16, 2020 (File No.
−Removed: 2019 Omnibus Equity Incentive Plan.
−Removed: Incorporated by reference to Appendix A to the proxy statement filed on October 1, 2019 (File No.
+Added: Underwriting Agreement, dated July 28, 2020, by and among Arcturus Therapeutics Holdings Inc., Citigroup Global Markets Inc., Guggenheim Securities, LLC, and Barclays Capital Inc.
+Added: Incorporated by reference to Exhibit 1.1 to Form 8-K filed on July 29, 2020 (File No.
Arcturus Therapeutics Ltd.
31 unchanged sentences
Third Amendment to Development and Option Agreement, by and between Arcturus Therapeutics, Inc.
−Removed: AG, dated July 26, 2019.
−Removed: Incorporated by refer ence to Exhibit 10.20 to Form 10-Q filed on August 14, 2019 (File No.
+Added: and CureVac AG, dated July 26, 2019.
+Added: Incorporated by reference to Exhibit 10.20 to Form 10-Q filed on August 14, 2019 (File No.
Co-Development and Co-Commercialization Agreement, by and between Arcturus Therapeutics, Inc.
35 unchanged sentences
Incorporated by reference to Exhibit 1.1 to Form 8-K filed on April 17, 2020 (File No.
+Added: Employment Agreement, dated as of June 13, 2019, between the Company and Joseph Payne.
+Added: Incorporated by reference to Exhibit 10.1 to Form 8-K12B filed on June 14, 2019 (File No.
+Added: Employment Agreement, dated as of June 13, 2019, between the Company and Andy Sassine.
+Added: Incorporated by reference to Exhibit 10.2 to Form 8-K12B filed on June 14, 2019 (File No.
+Added: Employment Agreement, dated as of June 13, 2019, between the Company and Dr.
+Added: Padmanabh Chivukula.
+Added: Incorporated by reference to Exhibit 10.3 to Form 8-K12B filed on June 14, 2019 (File No.
+Added: Registration Rights Agreement, dated as of June 18, 2019, between the Company and Ultragenyx Pharmaceutical Inc.
+Added: Incorporated by reference to Exhibit 4.1 to Form 8-K filed on June 20, 2019 (File No.
+Added: Equity Purchase Agreement, dated as of June 18, 2019, between the Company and Ultragenyx Pharmaceutical Inc.
+Added: Incorporated by reference to Exhibit 10.1 to Form 8-K filed on June 20, 2019 (File No.
Certification by Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended.
5 unchanged sentences
101.INS XBRL Instance Document
−Removed: 101.SCH XBRL Taxonomy Extension Schema
−Removed: 101.CAL XBRL Taxonomy Extension Calculation Linkbase
−Removed: 101.DEF XBRL Taxonomy Extension Definition Linkbase
−Removed: 101.LAB XBRL Taxonomy Extension Label Linkbase
−Removed: 101.PRE XBRL Taxonomy Extension Presentation Linkbase
+Added: 101.SCH XBRL Taxonomy Extension Schema Document
+Added: 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
+Added: 101.DEF XBRL Taxonomy Extension Definition Linkbase Document
+Added: 101.LAB XBRL Taxonomy Extension Labels Linkbase Document
+Added: 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
Filed herewith.
−Removed: Certain confidential portions of this exhibit have been redacted from the publicly filed document because such portions are (i) not material and (ii) would be competitively harmful of publicly disclosed.
+Added: Certain confidential portions of this exhibit have been redacted from the publicly filed document because such portions are (i) not material and (ii) would be competitively harmful if publicly disclosed.
Management compensatory plan, contract or arrangement.
1 unchanged sentence
ARCTURUS THERAPEUTICS HOLDINGS INC.
−Removed: /s/ Andy Sassine
+Added: August 10, 2020
+Added: /s/ Andrew Sassine
+Added: Andrew Sassine
Chief Financial Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.